Abstract |
Total synthesis of englerin A, a recently reported sesquiterpenoid exhibiting potent and selective growth inhibition against renal cancer cell lines, has been accomplished. The successful strategy featured a [5 + 2] cycloaddition reaction to cast the seven-membered oxabicyclic key intermediate in both racemic and optically active forms. Synthetic (+/-)- englerin A, (+/-)- englerin B, (+/-)- englerin B acetate, a hydroxy acetate, a tert-butyldimethylsilyl ether, and hydrogenated (+/-)- englerin A (31) were tested for their cytotoxicity against a selected panel of cancer cell lines, and the results are path-pointing to more focused structure-activity relationship studies.
|
Authors | K C Nicolaou, Qiang Kang, Sin Yee Ng, David Y-K Chen |
Journal | Journal of the American Chemical Society
(J Am Chem Soc)
Vol. 132
Issue 23
Pg. 8219-22
(Jun 16 2010)
ISSN: 1520-5126 [Electronic] United States |
PMID | 20496885
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Acetates
- Antineoplastic Agents
- Esters
- Sesquiterpenes, Guaiane
- englerin A
- englerin B
|
Topics |
- Acetates
(chemistry)
- Antineoplastic Agents
(chemical synthesis, chemistry, pharmacology)
- Cell Line, Tumor
- Esters
(chemistry)
- Humans
- Inhibitory Concentration 50
- Kidney Neoplasms
(pathology)
- Sesquiterpenes, Guaiane
(chemical synthesis, chemistry, pharmacology)
- Stereoisomerism
|